» Articles » PMID: 19038891

Emergence of Extensive Drug Resistance During Treatment for Multidrug-resistant Tuberculosis

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2008 Nov 29
PMID 19038891
Citations 36
Authors
Affiliations
Soon will be listed here.
Citing Articles

Association between HIV and acquisition of rifamycin resistance with first-line TB treatment: a systematic review and meta-analysis.

Zinyakatira N, Ford N, Cox H BMC Infect Dis. 2024; 24(1):657.

PMID: 38956461 PMC: 11218187. DOI: 10.1186/s12879-024-09514-7.


Rapid Detection of Extensive Drug Resistance by Xpert MTB/XDR Optimizes Therapeutic Decision-Making in Rifampin-Resistant Tuberculosis Patients.

Chen X, Li R, Ge S, Li Y, Cai C, Weng T J Clin Microbiol. 2023; 61(6):e0183222.

PMID: 37249422 PMC: 10281159. DOI: 10.1128/jcm.01832-22.


Evolution and epidemic success of Mycobacterium tuberculosis in eastern China: evidence from a prospective study.

Zhou Z, Yi H, Zhou Q, Wang L, Zhu Y, Wang W BMC Genomics. 2023; 24(1):241.

PMID: 37147590 PMC: 10161668. DOI: 10.1186/s12864-023-09312-6.


Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement.

Dominguez J, Boeree M, Cambau E, Chesov D, Conradie F, Cox V Lancet Infect Dis. 2023; 23(4):e122-e137.

PMID: 36868253 PMC: 11460057. DOI: 10.1016/S1473-3099(22)00875-1.


High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.

Dreyer V, Mandal A, Dev P, Merker M, Barilar I, Utpatel C Genome Med. 2022; 14(1):95.

PMID: 35989319 PMC: 9394022. DOI: 10.1186/s13073-022-01076-0.